These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 7856099)

  • 41. Differential regulation of Epstein-Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain.
    Trivedi P; Spinsanti P; Cuomo L; Volpe M; Takada K; Frati L; Faggioni A
    J Virol; 2001 May; 75(10):4929-35. PubMed ID: 11312367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael.
    Masucci MG; Contreras-Salazar B; Ragnar E; Falk K; Minarovits J; Ernberg I; Klein G
    J Virol; 1989 Jul; 63(7):3135-41. PubMed ID: 2470924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. H2O2 inhibits BCR-dependent immediate early induction of EBV genes in Burkitt's lymphoma cells.
    Osipova-Goldberg HI; Turchanowa LV; Adler B; Pfeilschifter JM
    Free Radic Biol Med; 2009 Oct; 47(8):1120-9. PubMed ID: 19540913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
    Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H
    Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata.
    Komano J; Sugiura M; Takada K
    J Virol; 1998 Nov; 72(11):9150-6. PubMed ID: 9765461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2.
    Burgstahler R; Kempkes B; Steube K; Lipp M
    Biochem Biophys Res Commun; 1995 Oct; 215(2):737-43. PubMed ID: 7488016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
    Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
    Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1.
    Chen F; Zou JZ; di Renzo L; Winberg G; Hu LF; Klein E; Klein G; Ernberg I
    J Virol; 1995 Jun; 69(6):3752-8. PubMed ID: 7745723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
    Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).
    Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R
    J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
    Jiménez-Ramírez C; Brooks AJ; Forshell LP; Yakimchuk K; Zhao B; Fulgham TZ; Sample CE
    J Virol; 2006 Nov; 80(22):11200-8. PubMed ID: 16956945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1.
    Zhang L; Pagano JS
    J Virol; 2000 Feb; 74(3):1061-8. PubMed ID: 10627515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.
    Schlager S; Speck SH; Woisetschläger M
    J Virol; 1996 Jun; 70(6):3561-70. PubMed ID: 8648690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants.
    Marchini A; Longnecker R; Kieff E
    J Virol; 1992 Aug; 66(8):4972-81. PubMed ID: 1321281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line.
    Szekely L; Chen F; Teramoto N; Ehlin-Henriksson B; Pokrovskaja K; Szeles A; Manneborg-Sandlund A; Löwbeer M; Lennette ET; Klein G
    J Gen Virol; 1998 Jun; 79 ( Pt 6)():1445-52. PubMed ID: 9634087
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Marked, transient inhibition of expression of the Epstein-Barr virus latent membrane protein gene in Burkitt's lymphoma cell lines by electroporation.
    Gahn TA; Sugden B
    J Virol; 1993 Nov; 67(11):6379-86. PubMed ID: 8411339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines.
    Inman GJ; Allday MJ
    J Gen Virol; 2000 Jun; 81(Pt 6):1567-78. PubMed ID: 10811940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
    Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD
    J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epstein-Barr virus latent and replicative gene expression in oral hairy leukoplakia.
    Sandvej K; Krenács L; Hamilton-Dutoit SJ; Rindum JL; Pindborg JJ; Pallesen G
    Histopathology; 1992 May; 20(5):387-95. PubMed ID: 1316871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.